Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02900027
What this trial is testing

Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated Triglycerides

Who this might be right for
Elevated Triglycerides (TG)
Ionis Pharmaceuticals, Inc. 56
Testing effectiveness (Phase 2)Ended earlyNCT04993391
What this trial is testing

AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Suzhou Junjing BioSciences Co., Ltd. 32
Early research (Phase 1)Looking for participantsNCT07150962
What this trial is testing

Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects

Who this might be right for
Overweight or Obesity
Fujian Shengdi Pharmaceutical Co., Ltd. 168
Early research (Phase 1)Study completedNCT02492789
What this trial is testing

A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients

Who this might be right for
Solid Tumors and Hematologic Malignancy
Atridia Pty Ltd. 49
Early research (Phase 1)Study completedNCT03905291
What this trial is testing

Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy Subjects

Who this might be right for
Healthy Volunteers
Medy-Tox 25
Early research (Phase 1)Study completedNCT01288391
What this trial is testing

Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 15
Early research (Phase 1)Study completedNCT01216384
What this trial is testing

Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers

Who this might be right for
AsthmaRhinitis, Allergic, Perennial
Boehringer Ingelheim 73
Early research (Phase 1)Study completedNCT04592549
What this trial is testing

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

Who this might be right for
SARS-CoV-2
Alachua Government Services, Inc. 48
Early research (Phase 1)Ended earlyNCT02134197
What this trial is testing

Dose-escalation Study of Lupartumab Amadotin (BAY1129980)

Who this might be right for
Neoplasms
Bayer 69
Testing effectiveness (Phase 2)Study completedNCT01267188
What this trial is testing

Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 10
Early research (Phase 1)Not Yet RecruitingNCT07791186
What this trial is testing

Safety, Tolerability, and Immunogenicity of BMI2012 Against COVID-19 Variant in Healthy Adults Aged 19 and 55 Years

Who this might be right for
Prevention of COVID-19 Variant (Omicron JN.1)
BMI Korea 72
Early research (Phase 1)Study completedNCT02346760
What this trial is testing

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers

Who this might be right for
Herpes Simplex Virus Infection
United BioPharma 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT01744223
What this trial is testing

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaLymphoma+1 more
Bellicum Pharmaceuticals 36
Early research (Phase 1)Study completedNCT05494918
What this trial is testing

First-In-Human Study in Subjects With Advanced or Metastatic Solid Malignant Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Solid Tumors
Alphamab (Australia) Co Pty Ltd. 62
Testing effectiveness (Phase 2)UnknownNCT04903873
What this trial is testing

Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorRenal Cell Cancer MetastaticNon-Small Cell Lung Cancer+2 more
Eutilex 110
Testing effectiveness (Phase 2)Study completedNCT03681860
What this trial is testing

EMaBS TB Vaccine Study

Who this might be right for
SafetyImmunogenicity
University of Oxford 72
Early research (Phase 1)Study completedNCT01410513
What this trial is testing

Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
Indolent Non-Hodgkin LymphomaMantle Cell LymphomaChronic Lymphocytic Leukemia
Sanofi 37
Early research (Phase 1)Study completedNCT01947920
What this trial is testing

A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers

Who this might be right for
Healthy
Janssen Scientific Affairs, LLC 30
Early research (Phase 1)Looking for participantsNCT06935682
What this trial is testing

Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects

Who this might be right for
Healthy Adult Male and Female Volunteers
Beijing Tiantan Hospital 36
Early research (Phase 1)Study completedNCT05582096
What this trial is testing

LY3457263 in Obese Participants

Who this might be right for
OverweightObesity
Eli Lilly and Company 38
Next Page